Pulsenmore Ltd PLSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
-
Pulsenmore Expands Its Fertility Platform into the UK
-
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
-
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
-
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
-
Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring
-
Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program
Trading Information
- Previous Close Price
- $1.81
- Day Range
- $1.79–1.86
- 52-Week Range
- $1.79–12.95
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 6.50M
- Market Cap
- $12.16M
- Volume/Avg
- 27,793 / 71,760
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 63
- Website
- https://www.pulsenmore.com
Valuation
|
Metric
|
PLSM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.76 |
Price/Sales | 0.93 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PLSM
|
|---|---|
Quick Ratio | 1.69 |
Current Ratio | 1.84 |
Interest Coverage | −1.67 |
Quick Ratio
PLSM
Profitability
|
Metric
|
PLSM
|
|---|---|
Return on Assets (Normalized) | −22.35% |
Return on Equity (Normalized) | −36.93% |
Return on Invested Capital (Normalized) | −22.02% |
Return on Assets
PLSM
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|thr^KP# | LOCK|ZWWgp | $181B | |||
| Medtronic PLC
MDT
| LOCK|BmTSlV | LOCK|LVtm | $121B | |||
| Stryker Corp
SYK
| LOCK|HP?PY%b& | LOCK|sW | $113B | |||
| Boston Scientific Corp
BSX
| LOCK|r#>%nK% | LOCK|C!xz< | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|^<z#kkFl | LOCK|!&M? | $50B | |||
| DexCom Inc
DXCM
| LOCK|#$GdZGSQ | LOCK|s$ccf | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|R#rs^>g | LOCK|P< | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|C&m | LOCK|^T | $25B | |||
| Steris PLC
STE
| LOCK|?w&THg | LOCK|$&&$H | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|Xc@n@dvN | LOCK|#%> | $18B |
United States